BTI
PACB icon

Blue Trust Inc’s Pacific Biosciences PACB Stock Holding History

Blue Trust Inc’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,033
Closed -$1.42K – 2826
2024
Q3 		$1.42K Sell
1,033
-3,054
-75% -$5.02K ﹤0.01% 2646
2024
Q2 		$15.3K Buy
+4,087
New +$8.25K ﹤0.01% 1776
2024
Q1 		– Sell
-1,766
Closed -$15K – 2572
2023
Q4 		$15K Buy
+1,766
New +$14.4K ﹤0.01% 1432
2023
Q3 		– Sell
-34
Closed – – 2228
2023
Q2 		$0 Buy
+34
New +$413 ﹤0.01% 2386
2023
Q1 		– Sell
-173
Closed -$1K – 2543
2022
Q4 		$1K Buy
173
+124
+253% +$1.07K ﹤0.01% 2107
2022
Q3 		$0 Hold
49
– – ﹤0.01% 2255
2022
Q2 		$0 Buy
+49
New +$298 ﹤0.01% 1973

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Blue Trust Inc's PACB Position: Q4 2024 in Review

Blue Trust Inc sold out of Pacific Biosciences (PACB) in Q4 2024, closing a stake of 1,033 shares — an estimated $1.42K sold.

Blue Trust Inc first reported a position in PACB in Q2 2022 and held it in 7 quarters. The position peaked at $15.3K in Q2 2024. 226 funds tracked by Wall St. Rank hold PACB as of Q4 2024.

  • Blue Trust Inc reported no remaining Pacific Biosciences position as of Q4 2024 after selling out during the quarter.
  • Blue Trust Inc sold 1,033 Pacific Biosciences shares in Q4 2024, an estimated $1.42K.
  • Blue Trust Inc first reported a position in Pacific Biosciences in Q2 2022 and held it in 7 quarters.
  • Blue Trust Inc's Pacific Biosciences position peaked at $15.3K in Q2 2024.
  • 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.